文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

经腹机器人辅助腹腔镜切除原发性腹膜后肿瘤的应用

[The application of robot-assisted laparoscopic resection of primary retroperitoneal tumors via the abdominal approach].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2025-01-01

本研究回顾性分析71例经腹机器人辅助腹腔镜切除原发性腹膜后肿瘤患者,按肿瘤是否粘连分为未粘连组(47例)与粘连组(24例)。结果显示该技术安全可行,粘连组手术时间更长、出血更多、并发症更多、恢复更慢,但两组均无围手术期死亡,3年复发转移率10.14%,3年病死率2.90%。

要点

  • 经腹机器人辅助腹腔镜切除原发性腹膜后肿瘤安全可行,围手术期无死亡。
  • 肿瘤粘连组手术时间、出血量、输血率、并发症及住院时间均劣于未粘连组。
  • 3年复发转移率10.14%,3年病死率2.90%。

核心结论

  • 经腹机器人辅助腹腔镜切除原发性腹膜后肿瘤安全可行,对粘连于周围器官或血管的肿瘤也可取得安全手术结局,但手术难度更高、术后恢复更慢。

研究设计与样本

  • 回顾性队列研究,纳入2015年1月至2023年12月浙江大学医学院附属邵逸夫医院泌尿外科71例经腹机器人辅助腹腔镜原发性腹膜后肿瘤切除术患者。
  • 男性35例,女性36例;年龄56(21)岁(范围21~83岁);肿瘤最大径46(31)mm(范围15~134 mm);良性58例,恶性13例。
  • 按是否与主要器官或血管粘连分为未粘连组(n=47)与粘连组(n=24),比较围手术期与术后恢复情况。

主要发现

  • 手术时间120(60)min(范围45~440 min),术中出血量50(80)ml(范围10~2 000 ml),术中平均动脉压波动40(19)mmHg(范围10~112 mmHg)。
  • 7例术中输血,64例未输血;手术前后血红蛋白变化量(17.9±13.6)g/L(范围-16~53 g/L),血肌酐变化量2.0(14.5)μmol/L(范围-71.0~100.4 μmol/L)。
  • 术后禁食2.0(1.5)d(范围1~6 d),住院时间10.0(7.5)d(范围4~24 d),无围手术期死亡。
  • 未粘连组手术时间、术中出血量、术中输血率、手术前后血红蛋白变化量、手术前后血肌酐变化量、术后并发症、术后禁食时间、住院时间均优于粘连组(P值均<0.05),术中平均动脉压波动无差异(P>0.05)。
  • 69例获得随访,随访时间39(43)个月(范围4~88个月),40例获得3年以上随访;3年复发转移率10.14%,3年病死率2.90%。

临床怎么用

  • 经腹机器人辅助腹腔镜可作为原发性腹膜后肿瘤的可选手术方式。
  • 对粘连于周围器官或血管的肿瘤,应预期手术难度增加、术后恢复减慢,做好围手术期准备。

局限性

  • 本研究为单中心回顾性队列分析,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the effect of robot-assisted laparoscopic technology via abdominal approach for patients with primary retroperitoneal tumors. Methods: A retrospective cohort analysis was conducted for the clinical data of 71 patients who underwent robot-assisted laparoscopic resection of primary retroperitoneal tumor via abdominal approach at the Department of Urology of Sir Run Run Shaw Hospital,Zhejiang University School of Medicine from January 2015 to December 2023. There were 35 male and 36 female patients. The age (M(IQR)) was 56(21) years (range: 21 to 83 years). The median tumor diameter was 46 (31) mm (range: 15 to 134 mm). Postoperative pathology revealed 58 benign and 13 malignant cases. Patients were divided into non-adherent group (n=47) and adherent group (n=24) based on whether the tumor was adhered to major organs or vessels. Perioperative and postoperative situation were compared between the two groups. Data comparisons were conducted using independent samples t-test for normally distributed continuous variables, Mann-Whitney U tests for non-normally distributed data, χ2 test or Fisher's exact test for categorical variables. Kaplan-Meier survival analysis was employed to estimate 3-year recurrence or metastasis rate and 3-year mortality rate. Results: Operative time was 120(60) minutes (range: 45 to 440 minutes), intraoperative blood loss was 50 (80) ml (range: 10 to 2 000 ml). The median change of intraoperative mean arterial pressure was 40 (19) mmHg(1 mmHg=0.133 kPa)(range: 10 to 112 mmHg). Intraoperative blood transfusion was required in 7 cases, whereas 64 cases did not necessitate transfusion. The change in hemoglobin levels before and after surgery was (17.9±13.6) g/L (range:-16 to 53 g/L), and the median change in serum creatinine levels was 2.0 (14.5) μmol/L (range:-71.0 to 100.4 μmol/L). Postoperative fasting duration was 2.0 (1.5) days (range: 1 to 6 days), and the median hospital stay was 10.0 (7.5) days (range: 4 to 24 days). No perioperative mortality occurred in any of the patients. The non-adherent group had shorter operation time, less estimated blood loss, lower blood transfusion rate, smaller delta value of hemoglobin before and after surgery, larger delta value of creatinine before and after surgery, fewer postoperative complications, shorter postoperative fasting time, and shorter length of hospital stay than the adherent group(all P<0.05), while there was no significant difference in mean arterial pressure fluctuation between the two groups (P>0.05). Follow-up data were available for 69 patients, with a median follow-up duration of 39 (43) months (range: 4 to 88 months). Among these patients, 40 completed the 3-year follow-up. The 3-year recurrence or metastasis rate was 10.14%, and the 3-year mortality rate was 2.90%. Conclusions: Robot-assisted laparoscopic technology via abdominal approach for resection of primary retroperitoneal tumors is safe and feasible. It can also achieve secure surgical outcome for primary retroperitoneal tumors adherent to surrounding organs or vessels, albeit with increased surgical complexity and slower postoperative recovery compared to non-adherent cases. 目的: 探讨经腹机器人辅助腹腔镜切除原发性腹膜后肿瘤的手术效果。 方法: 本研究为回顾性队列研究。回顾性分析2015年1月至2023年12月在浙江大学医学院附属邵逸夫医院泌尿外科行经腹入路机器人辅助腹腔镜原发性腹膜后肿瘤切除术的71例患者的临床资料。男性35例,女性36例,年龄[M(IQR)]56(21)岁(范围:21~83岁)。肿瘤最大径46(31)mm(范围:15~134 mm);术后病理学检查结果显示,良性肿瘤58例,恶性肿瘤13例。根据是否与主要器官或血管粘连分为未粘连组(n=47)与粘连组(n=24),比较两组患者的围手术期情况与术后恢复情况。数据比较采用独立样本t检验、Mann-Whitney U检验、χ2检验或Fisher确切概率法。采用Kaplan-Meier法绘制生存曲线并计算患者复发转移率和病死率。 结果: 所有患者的手术均顺利完成,手术时间为120(60)min(范围:45~440 min),术中出血量为50(80)ml(范围:10~2 000 ml);术中平均动脉压波动40(19)mmHg(1 mmHg=0.133 kPa)(范围:10~112 mmHg);64例患者术中未输血,7例术中输血;手术前后血红蛋白变化量为(17.9±13.6)g/L(范围:-16~53 g/L),手术前后血肌酐变化量为2.0(14.5)μmol/L(范围:-71.0~100.4 μmol/L);术后禁食2.0(1.5)d(范围:1~6 d),住院时间10.0(7.5)d(范围:4~24 d)。患者均未发生围手术期死亡。未粘连组的手术时间、术中出血量、术中输血率、手术前后血红蛋白变化量、手术前后血肌酐变化量、术后并发症情况、术后禁食时间、住院时间均优于粘连组(P值均<0.05),术中平均动脉压波动情况无差异(P>0.05)。69例患者获得随访,随访时间39(43)个月(范围:4~88个月),其中40例患者获得3年以上随访。生存分析结果显示,3年复发转移率为10.14%,3年病死率为2.90%。 结论: 机器人辅助腹腔镜经腹切除原发性腹膜后肿瘤是可选择的手术方式,切除与周围器官或血管粘连的原发性腹膜后肿瘤可取得安全的手术结局,但较未粘连者手术难度高、术后恢复慢。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zang RC, Gao FB, Wang KY, et al. [The application of robot-assisted laparoscopic resection of primary retroperitoneal tumors via the abdominal approach]. Zhonghua Wai Ke Za Zhi. 2025. PMID: 41015481. doi:10.3760/cma.j.cn112139-20241112-00504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。